Projects
Approved TransSCOT projects:
TransSCOT Number | Title | PI | Status | Publication |
---|---|---|---|---|
1 | Investigating molecular markers in samples collected from patients with colorectal Cancer | David Church, Iain Tomlinson, Owen Samson (Oxford, Edinburgh, Glagsow) | in progress | pending |
4 | Tumour Budding as a predictor of response and survival in colorectal Cancer | Viktor Koelzer (Zurich) | analysis phase | in progress |
5 | colorectal Cancer phenotypic subtypes as a predictor of response to therapy | Joanne Edwards (Glasgow) | complete | Published. DOI.10.1002/cjp2.171 |
7 | Immunoscore of colorectal Cancer | Halio Dx (France) | analysis phase | in progress |
8 | Image-Based transciptional classificatin of colorecta; tumours as predictor od repsonse and survival in colorectal Cancer | Viktor Koelzer, Tim Maughan, Jens Rittscher (Zurich, Oxford) | complete | in progress |
12 | In Silico Pathology, Large Scale genomic instability and new prognostic biomarkers in colorectal cancer | Havard Danielsen (Norway) | in progress | pending |
13 | Genomic Analysis of the tumour and its microenvironment to predict response in adjuvant chemotherapy in colon cancer | Campbell Roxburgh (Glasgow) | in progress | pending |
17 | Prediction of microsatellite status, BRAF Status and overall survival in colorectal cancer directly from histologywith deep learning | Jakub Kather (Germany) | analysis phase | in progress |
18 | Mismatch repair deficiency in colorectal cancer | David Church (Oxford) | analysis phase | in progress |
19 | IKKa as a potential novel target for treatment in colorectal cancer | Joanne Edwards (Glasgow) | analysis phase | in progress |
20 | Identification of metabolic signatures which define therapeutic efficacy in colorectal cancer | Andrew Campbell (Glasgow) | analysis phase | in progress |
24 | Determine progrnosis valu of phosphorylated STAT3(705) expression in patients undergoing different chemotherapeutic regimes in colorectal cancer | Joanne Edwards/Kathryn Pennel (Glasgow) | analysis phase | in progress |
25 | Molecular determinats of anti-tumour immune response and clinical otcomes in colorectal cancer | David Church(Glasgow and Viktor Koelzer (Zurich) | analysis phase | in progress |
28 | How ki67 analysis differs in digital pathology platforms and the associations with survival, recurrance and stages of cancer | Matthew Macfarlane (Glasgow) | analysis phase | in progress |